NCT07311200RecruitingPhase 2
A Study of D-2570 in Patients With Active Systemic Lupus Erythematosus (SLE)
A Phase II, Multicenter, Randomized, Double-Blind, Placebo-Controlled Clinical Study to Evaluate the Efficacy and Safety of D-2570 in Patients With Active Systemic Lupus Erythematosus
Source: ClinicalTrials.gov · Last updated 24 Apr 2026
Brief summary (registry, in English)
This study is a multicenter, randomized, double-blind, placebo-controlled Phase II clinical trial designed to evaluate the efficacy and safety of D-2570 in the treatment of active systemic lupus erythematosus.
- Status (registry)
- Recruiting
- Phase (registry)
- Phase 2
- Study type
- Interventional
- Enrollment
- 120 (estimated)
- First submitted
- 16 Dec 2025
- Start date
- 12 Feb 2026
- Primary completion date
- 31 Aug 2028
- Lead sponsor
- InventisBio Co., Ltd
- Diseases
- Lupus (SLE)
- NCT number
- NCT07311200
What you commit to
- Study type: Interventional · Phase 2
- Planned participants: 120
- From 12 Feb 2026 to the primary completion date, 31 Aug 2028
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- History of infection as defined in the protocol.
- Any of the medical diseases or disorders listed in the protocol.
- Significant, uncontrolled or unstable disease in any organ.
Who the study is looking for
- The patient voluntarily participates in this study after full informed consent.
- The age is 18 years ≤ age ≤ 70 years, regardless of gender.
- Diagnosed with Systemic Lupus Erythematosus (SLE) at least ≥ 24 weeks prior to screening.
- SLEDAI-2K total score ≥ 8.
- On stable treatment for systemic lupus erythematosus at least 4 weeks prior to randomization, and should remain at a stable dose throughout the trial period.
Age in the registry: 18 years to 70 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Linfen Central Hospital Coordinator of this site? Confirm its status | Linfen | China | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.